GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Acarix AB (FRA:7AC) » Definitions » ROA %

Acarix AB (FRA:7AC) ROA % : -96.73% (As of Sep. 2024)


View and export this data going back to 2016. Start your Free Trial

What is Acarix AB ROA %?

ROA % is calculated as Net Income divided by its average Total Assets over a certain period of time. Acarix AB's annualized Net Income for the quarter that ended in Sep. 2024 was €-6.54 Mil. Acarix AB's average Total Assets over the quarter that ended in Sep. 2024 was €6.77 Mil. Therefore, Acarix AB's annualized ROA % for the quarter that ended in Sep. 2024 was -96.73%.

The historical rank and industry rank for Acarix AB's ROA % or its related term are showing as below:

FRA:7AC' s ROA % Range Over the Past 10 Years
Min: -117.61   Med: -51.62   Max: -19.38
Current: -103.08

During the past 10 years, Acarix AB's highest ROA % was -19.38%. The lowest was -117.61%. And the median was -51.62%.

FRA:7AC's ROA % is ranked worse than
91.59% of 868 companies
in the Medical Devices & Instruments industry
Industry Median: -2.04 vs FRA:7AC: -103.08

Acarix AB ROA % Historical Data

The historical data trend for Acarix AB's ROA % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Acarix AB ROA % Chart

Acarix AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
ROA %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -51.59 -48.68 -49.41 -78.39 -116.55

Acarix AB Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
ROA % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -138.86 -177.80 -74.88 -76.07 -96.73

Competitive Comparison of Acarix AB's ROA %

For the Medical Devices subindustry, Acarix AB's ROA %, along with its competitors' market caps and ROA % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Acarix AB's ROA % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Acarix AB's ROA % distribution charts can be found below:

* The bar in red indicates where Acarix AB's ROA % falls into.



Acarix AB ROA % Calculation

Acarix AB's annualized ROA % for the fiscal year that ended in Dec. 2023 is calculated as:

ROA %=Net Income (A: Dec. 2023 )/( (Total Assets (A: Dec. 2022 )+Total Assets (A: Dec. 2023 ))/ count )
=-6.959/( (6.32+5.622)/ 2 )
=-6.959/5.971
=-116.55 %

Acarix AB's annualized ROA % for the quarter that ended in Sep. 2024 is calculated as:

ROA %=Net Income (Q: Sep. 2024 )/( (Total Assets (Q: Jun. 2024 )+Total Assets (Q: Sep. 2024 ))/ count )
=-6.544/( (7.053+6.478)/ 2 )
=-6.544/6.7655
=-96.73 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROA %, the net income of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Net Income data used here is four times the quarterly (Sep. 2024) net income data. ROA % is displayed in the 30-year financial page.


Acarix AB  (FRA:7AC) ROA % Explanation

ROA % measures the rate of return on the total assets (shareholder equity plus liabilities). It measures a firm's efficiency at generating profits from shareholders' equity plus its liabilities. ROA % shows how well a company uses what it has to generate earnings. ROA %s can vary drastically across industries. Therefore, ROA % should not be used to compare companies in different industries. For retailers, a ROA % of higher than 5% is expected. For example, Wal-Mart (WMT) has a ROA % of about 8% as of 2012. For banks, ROA % is close to their interest spread. A bank’s ROA % is typically well under 2%.

Similar to ROE, ROA % is affected by profit margins and asset turnover. This can be seen from the Du Pont Formula:

ROA %(Q: Sep. 2024 )
=Net Income/Total Assets
=-6.544/6.7655
=(Net Income / Revenue)*(Revenue / Total Assets)
=(-6.544 / 0.348)*(0.348 / 6.7655)
=Net Margin %*Asset Turnover
=-1880.46 %*0.0514
=-96.73 %

Note: The Net Income data used here is four times the quarterly (Sep. 2024) net income data. The Revenue data used here is four times the quarterly (Sep. 2024) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Like ROE, ROA % is calculated with only 12 months data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. ROA % can be affected by events such as stock buyback or issuance, and by goodwill, a company's tax rate and its interest payment. ROA % may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).

Many analysts argue the higher return the better. Buffett states that really high ROA % may indicate vulnerability in the durability of the competitive advantage.

E.g. Raising $43b to take on KO is impossible, but $1.7b to take on Moody's is. Although Moody's ROA % and underlying economics is far superior to Coca Cola, the durability is far weaker because of lower entry cost.


Acarix AB ROA % Related Terms

Thank you for viewing the detailed overview of Acarix AB's ROA % provided by GuruFocus.com. Please click on the following links to see related term pages.


Acarix AB Business Description

Traded in Other Exchanges
Address
World Trade Center Malmo, Jungmansgatan 12, Malmo, SWE, 211 19
Acarix AB is a Swedish medical technology company that develops innovative solutions for rapid AI-based exclusion of coronary artery disease (CAD). The CE-marked CADScor System, which has also received DeNovo approval from the FDA, is intended for patients experiencing chest pain with suspected coronary artery disease and is designed to help reduce millions of cases of unnecessary, invasive, and costly diagnostics. The CADScor System uses advanced acoustics and AI technology to non-invasively rule out CAD in less than 10 minutes, with at least 96 percent certainty.

Acarix AB Headlines

No Headlines